Understand the source comparison
Best Peptides for Overtraining Syndrome: Full Comparison
Before selecting peptides for OTS recovery, understand how each compound's mechanism aligns with your specific dysregulation pattern. Immune suppression, inflammatory persistence, or autonomic imbalance. BPC-157 NO pathway modulation, gut-barrier restoration S
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Before selecting peptides for OTS recovery, understand how each compound's mechanism aligns with your specific dysregulation pattern. Immune suppression, inflammatory persistence, or autonomic imbalance.
- BPC-157
- NO pathway modulation, gut-barrier restoration
- Systemic inflammation, intestinal permeability, tissue repair
- 250–500 mcg subcutaneous daily
- ~4 hours (frequent dosing)
- Best first-line choice for athletes with GI symptoms, persistent inflammation, or tendon/ligament issues alongside OTS
- TB-500
- Actin regulation, cytokine modulation, angiogenesis
- Tissue regeneration, immune hyperactivity, muscle recovery
- 2–5 mg subcutaneous 2x/week
- 7–10 days
- Ideal for structural tissue damage (muscle, tendon) combined with immune dysregulation. Not primarily an anti-fatigue agent
- Thymosin Alpha-1
- T-cell maturation, TLR signaling, immune reconstitution
- Suppressed T-cell counts, infection susceptibility, immune exhaustion
- 1.6 mg subcutaneous 2x/week
- 2–3 hours (effects persist days)
- Most targeted for confirmed immune suppression (low CD4+/CD8+ counts). Requires baseline immune panel for monitoring
- Epithalon
- Telomerase activation, melatonin regulation, circadian rhythm
- HPA axis normalization, sleep architecture, cortisol rhythm
- 5–10 mg subcutaneous for 10–20 days
- 6–8 hours
- Experimental application for circadian dysregulation in OTS. Limited human data compared to BPC-157/TB-500
- Selank
- BDNF upregulation, GABA-A modulation, anxiolytic effects
- Central fatigue, autonomic imbalance, cognitive symptoms
- 250–500 mcg intranasal daily
- 25 minutes (CNS effects 3–6 hours)
- Addresses psychological/neurological symptoms of OTS but does not target immune or inflammatory pathways directly